Annual Current Liabilities
$9.77 M
+$2.90 M+42.20%
December 31, 2023
Summary
- As of February 8, 2025, ELTX annual total current liabilities is $9.77 million, with the most recent change of +$2.90 million (+42.20%) on December 31, 2023.
- During the last 3 years, ELTX annual current liabilities has risen by +$6.46 million (+195.26%).
- ELTX annual current liabilities is now -48.28% below its all-time high of $18.88 million, reached on December 31, 2021.
Performance
ELTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$9.02 M
+$1.44 M+18.92%
September 30, 2024
Summary
- As of February 8, 2025, ELTX quarterly total current liabilities is $9.02 million, with the most recent change of +$1.44 million (+18.92%) on September 30, 2024.
- Over the past year, ELTX quarterly current liabilities has dropped by -$2.47 million (-21.47%).
- ELTX quarterly current liabilities is now -21.47% below its all-time high of $11.49 million, reached on September 30, 2023.
Performance
ELTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ELTX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +42.2% | -21.5% |
| 3 y3 years | +195.3% | - |
| 5 y5 years | +459.2% | - |
ELTX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.3% | +42.2% | -21.5% | +157.7% |
| 5 y | 5-year | -48.3% | +459.2% | -21.5% | +157.7% |
| alltime | all time | -48.3% | +459.2% | -21.5% | +157.7% |
Elicio Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.02 M(+18.9%) |
| Jun 2024 | - | $7.58 M(+27.5%) |
| Mar 2024 | - | $5.95 M(-39.1%) |
| Dec 2023 | $9.77 M | $9.77 M(-15.0%) |
| Sep 2023 | - | $11.49 M(+51.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $7.60 M(+10.6%) |
| Dec 2022 | $6.87 M(-63.6%) | $6.87 M(+96.2%) |
| Dec 2021 | $18.88 M(+470.9%) | - |
| Mar 2021 | - | $3.50 M |
| Dec 2020 | $3.31 M(+89.4%) | - |
| Dec 2019 | $1.75 M | - |
FAQ
- What is Elicio Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Elicio Therapeutics?
- What is Elicio Therapeutics annual current liabilities year-on-year change?
- What is Elicio Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Elicio Therapeutics?
- What is Elicio Therapeutics quarterly current liabilities year-on-year change?
What is Elicio Therapeutics annual total current liabilities?
The current annual current liabilities of ELTX is $9.77 M
What is the all time high annual current liabilities for Elicio Therapeutics?
Elicio Therapeutics all-time high annual total current liabilities is $18.88 M
What is Elicio Therapeutics annual current liabilities year-on-year change?
Over the past year, ELTX annual total current liabilities has changed by +$2.90 M (+42.20%)
What is Elicio Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ELTX is $9.02 M
What is the all time high quarterly current liabilities for Elicio Therapeutics?
Elicio Therapeutics all-time high quarterly total current liabilities is $11.49 M
What is Elicio Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ELTX quarterly total current liabilities has changed by -$2.47 M (-21.47%)